Knowledge of mechanisms involved in vulnerability/resilience to stress disorders is crucial for prevention and treatment schemes. We previously documented that insulinlike growth factor I (IGF-I) is associated to vulnerability to stress both in mice and humans. Since hypothalamic orexin neurons express IGF-I receptors and are involved in responses to stress, we analyzed their role in the modulatory actions of IGF-I on stress.
Introduction
Exposure to a traumatic event affects a large part of the world population, but only a relatively small proportion will develop a post-traumatic stress disorder (Shalev et al., 2017) . However, specific subsets of the population are at greater risk, such as soldiers exposed to combat (Yurgil et al., 2014) . Unfortunately, treatment of this mental condition remains largely unsatisfactory (DePierro et al., 2019) . Mechanisms of vulnerability and resilience to PTSD are therefore crucial to treat, and even prevent, this psychiatric illness. Since we recently found that IGF-I is associated to vulnerability to stress in mice and humans (Santi et al., 2018b) , we have explored underlying mechanisms with the hope to gain insight into novel processes affecting vulnerability/resilience to stress in general, and to PTSD development more specifically.
Modulatory actions of IGF-I on mood are increasingly recognized (Lin et al., 2014; van Varsseveld et al., 2015; Kondo et al., 2017; Santi et al., 2018b) . The relation of circulating IGF-I with mood encompasses multiple angles, such as anxiolysis (Baldini et al., 2013; Santi et al., 2018b) , arousal (Bellar et al., 2011) , playfulness (Burgdorf et al., 2010) , or depression (Deuschle et al., 1997; Kondo et al., 2017) . The latter aspect is profusely documented in the literature. In search for possible cellular targets of IGF-I in mood modulation we focused on the hypothalamus, a brain area that expresses abundant IGF-I receptors (http://mouse.brain-map.org/experiment/ show?id=69735263) and is central in neuroendocrine regulation of stress (Ulrich-Lai and Herman, 2009 ). Within the hypothalamus, orexin neurons are involved in responses to stress (Ji et al., 2019) and pharmacological modulation of their activity has been proposed as possible therapy for PTSD (Flores et al., 2015; Soya and Sakurai, 2018; Cohen et al., 2020) . These neurons are also involved in mood regulation in general (Harris et al., 2005; Johnson et al., 2010; Blouin et al., 2013) , and mood-related traits such as motivated behaviors (Mahler et al., 2014; Sakurai, 2014) , or arousal (Yamanaka et al., 2003) . Recently, orexin neurons have been shown to be directly involved in PTSD-like responses in rats (Cohen et al., 2020) . Thus, we hypothesized that orexin neurons may participate in the regulation of stress responses by IGF-I.
In this work we report that a functional link between IGF-I and orexin is involved in vulnerability to stress. Mice with disrupted IGF-IR activity in orexin neurons developed PTSD-like traits including exacerbated fear conditioning, delayed extinction of fear, and post-stress anhedonia. Abnormally high orexin activation underlies this phenotype, as their chemogenetic inhibition ameliorated it.
Results

Anxiolytic actions of IGF-I involve orexin neurons
We recently found that IGF-I directly modulates the activity of orexin neurons (submitted). Since IGF-I reduces anxiety in mice exposed to a predator (Santi et al., 2018b ), a natural anxiogenic stimulus (Blanchard et al., 2003) , we administered IGF-I (icv) to mice expressing an inactive IGF-IR in orexin neurons (Firoc mice) and their control littermates, before exposing them to a rat ( Figure 1 ). We observed reduced anxiety in littermate controls treated with IGF-I, but not in Firoc mice, as determined by reduced entrance to the open arms in the elevated plus maze (EPM; Figure 1C ). Other parameters measuring fear behavior during predator exposure (freezing and grid contacts), and a subsequent test in the open field indicating enhanced anxiety, were also significantly ameliorated by IGF-I treatment in control, but not in mutant mice ( Figure   1B ,D). Lack of anxiolytic actions of IGF-I in Firoc mice suggests that these neurons are involved in stress regulation by IGF-I.
IGF-I modulates orexin responses to fear learning
Based on the above observations, we hypothesized that Firoc mice could show disturbed fear learning. Hence, we submitted them to fear conditioning (Figure 2A ), and found that Firoc mice showed increased fear responses, as measured by time spent in freezing behavior ( Figure 2B and Suppl Fig 1A,B ). Firoc mice exposed to fear conditioning also showed increased number of activated orexin (double labeled cfos/orexin neurons; Figure (Soya et al., 2017) .
Since these observations suggested increased activation of orexin neurons in Firoc mice submitted to fear conditioning, we chemogenetically inhibited orexin activity.
After bilateral injection of an inhibitory DREADD-Cre virus into the lateral hypothalamus of Orexin-Cre (controls) and Firoc mice, we administered CNO to fearconditioned mice and found that Firoc mice normalized their fear responses ( Figure   4A ). Control littermates and Firoc mice injected with mCherry viruses show normal or exaggerated fear responses, respectively, as expected. These data suggest that orexin neurons in Firoc mice are overactivated.
4
Firoc mice display PTSD-like traits
Abnormal fear learning is suggested to underlie PTSD (Shalev et al., 2017) . Taking advantage that chemogenetic inactivation of orexin neurons in Firoc mice rescues exaggerated fear learning, we examined possible development of PTSD-like traits and its attenuation with DREADD inhibition in Firoc mice. Extinction of contextdependent fear responses (context recall) 1 week later were markedly attenuated in Firoc mice injected with mCherry virus as compared to mCherry-injected littermate controls, indicating abnormal retention of learned fear ( Figure 5A ), a trait seen in PTSD patients. Interestingly, these mice also showed higher levels of orexin in the hypothalamus after fear conditioning ( Figure 5B ). We also found that after fear conditioning, Firoc mice developed anhedonia, as measured by the sucrose-preference test ( Figure 5C ), another characteristic of PTSD patients. Importantly, Firoc mice did not show anhedonia under basal conditions (not shown).
Discussion
These results indicate that IGF-I modulates responses to stress through hypothalamic orexin neurons. Regulation of orexin activity by IGF-I probably forms part of homeostatic regulation of these neurons (Azeez et al., 2018) . We show that the IGF-I receptor in orexin neurons modulate both acquired (fear learning), and innate fear (predator exposure) responses, providing a specific molecular mechanism for vulnerability to aberrant responses to stress. Indeed, blunted IGF-I input to orexin neurons in Firoc mice favors the appearance of PTSD-like behavior, including retention of fear memories, anhedonia and altered sensitivity to dexametasone, three traits observed in human patients (Pietrzak et al., 2014) . Significantly, the PTSD-like phenotype of Firoc mice is normalized by chemogenetic inhibition of orexin overactivity. These findings reinforce the previously reported use of orexin receptor antagonists for treatment of this important mental illness (Flores et al., 2015; Soya and Sakurai, 2018) .
Conversely, recent observations pose orexin activation in response to fear stimuli (predator smell) as a resilient mechanism (Cohen et al., 2020) . These two apparently opposing observations may be reconciled with our findings. Since anxiolytic actions of IGF-I require signaling onto orexin neurons (Figure 1 ), IGF-I may modulate orexin activity in response to fear stimuli to cope with them, as suggested by Cohen et al (Cohen et al., 2020) . In turn, in the absence of IGF-I input (Firoc mice), orexin activity becomes maladaptive; i.e.: greater expression of orexin and increased number of double-labelled c-fos + /orexin + and c-fos + /TH + cells are found in Firoc mice after fear conditioning, as compared to littermates. Moreover, Firoc mice show impaired fear extinction. Thus, inappropriate activation of the orexin-LC circuitry will lead to aberrant fear behavior, as suggested by others (Soya et al., 2017) .
The fact that a pleiotropic neurotrophic factor such as IGF-I (Fernandez and Torres-Aleman, 2012) modulates the activity of orexin neurons, considered also a multitasking system (Sakurai, 2014) , help to explain the diversity of actions of IGF-I in the brain, including regulation of mood. Indeed, numerous reports relate IGF-I with affective disorders (Deuschle et al., 1997; Hoshaw et al., 2008; Kim et al., 2013; Lin et al., 2014; Bot et al., 2016; Chigogora et al., 2016) , and specific potential mechanisms have been started to unfold. For example, recent observations indicate that IGF-I participates in depression through its role in the serotonin system (Kondo et al., 2017) , while others related it to its involvement in adult hippocampal neurogenesis (Anderson et al., 2002) .
Thus, our observations widen the number of potential mechanisms whereby IGF-I intervenes in mood homeostasis, now including the orexinergic system, which emphasizes the complexity of mechanisms mediating the actions of this growth factor, even within the same category of activities.
Materials and Methods
Materials. Antibodies used include rabbit polyclonal anti-c-Fos (1:500 dilution, sc-52, Santa Cruz Biotechnology), monoclonal anti-orexin-A (1:100 dilution, sc-80263, Santa Cruz), and polyclonal anti-tyrosine hydroxylase (1:1000 dilution, MAB318, Millipore). Cued-fear conditioning. Experiments were performed at the same time of the day during the light phase with 3-4 months-old male and female mice (n=14-19 mice/genotype, balanced sex). The training and test sessions were video recorded. Mice were placed in a shuttle box chamber (AccuScan Instruments) for 120 sec before exposing them to a neutral conditioned stimulus (CS+) -a tone of 80 dB for 30s, presented together with an aversive unconditioned stimulus (US) -an electrical footshock of 0.3 mA/2 sec. Training consisted of 5 consecutive trials with 90 sec intertrials (CS-). Animals remained in the chamber for 5 min more before returning them to their home cages. Twenty four hours later, fear conditioning was tested placing the animals in a different context using the same protocol but without the unconditioned stimulus (US). As a consequence of the US-CS association, mice displayed freezing behavior, which was scored for every trial (CS+), and intertrial (CS-). Freezing behavior was defined by the absence of movement except of breathing and heart beating.
Context-dependent extinction was tested 1 week later (delayed extinction). Mice were 8 placed in the same context for 5 min to measure their freezing behavior. The latter unveils PTSD-like behaviour when it is abnormally retained.
Predator exposure test. Control littermates and Firoc mice implanted with osmotic minipumps (either with saline or IGF-I, see below), were introduced into a box for 10 min with two compartments separated by a plastic grid, one containing a rat (predator) and the other empty. The box contained bedding of the rat with urine and feces. All sessions were recorded, and every rat exposed to a maximum of 4 mice/day. Grid contacts, freezing time and bedding burying behaviors of exposed mice were scored. Sucrose preference test. Mice were given 2 bottles of water for 3 days, and then 2 bottles of 2% sucrose for 2 days. Afterwards, mice were deprived of food and water for 18h and then, they were presented a bottle of water and a bottle of 2% sucrose during 2h. The position of the bottles was switched after 1h. Bottles were placed in the active phase. Water and sucrose consumption was recorded and sucrose preference was defined as the ratio of the weight of sucrose intake to the weight of total intake of liquid (water and sucrose).
Immunocytochemistry. Mice were perfused transcardially under deep anesthesia (sodium pentobarbital, 50 mg/kg, i.p.) with 100 ml of saline buffer 0,9% followed by 100 ml of 4% paraformaldehyde (PFA) in 0.1N, pH 7.4 phosphate buffer (PB), 90 min after the cued-fear conditioning test. This time was selected as optimal to see c-Fos staining. The brains were removed, postfixed overnight at 4ºC in the same fixative, and cut at 50 µm thick sections on a vibratome (Leica VT 1000S). Sections were kept at 4ºC, immersed in 0.1N PB with 0.02% sodium azide, until processing. Serial coronal free-floating sections were rinsed in 0.1N PB for 10 min, and a blocking solution containing 10% normal donkey serum (NDS) and 0.4% Triton X-100 in 0.1N PB was added, and maintained at room temperature for 2 h. Thereafter, sections were incubated overnight at 4ºC in the same solution with the corresponding primary antibodies. The next day, sections were washed 3 times with PB-0.4% Triton X-100 (PB-T), and incubated with secondary antibodies AlexaFluor-488 donkey anti-rabbit (1:1000 dilution, A-21206, Life Technologies), and AlexaFluor-594 donkey anti-mouse (1:1000 dilution, A-21203, Life Technologies) for 2 h at room temperature. After the incubation, slices were washed 3 times with PB-T and incubated 5 min with Hoescht (1:500 dilution, Life Technologies). Finally, sections were washed 3 times with PB and mounted onto glass slides coated with gelatin in Gelvatol mounting medium. Images were taken with confocal microscopy (SP5, Leica Microsystems, Germany) and cell counting was performed with Imaris software.
qPCR. Animals were anesthetized with pentobarbital (50 mg/kg, ip). After dissecting the brain, the different brain areas were collected and frozen at -80ºC until use. Tissue RNA was extracted with Trizol (Life Technologies, USA), as described elsewhere (Santi et al., 2018a) . cDNA was synthesized from 1μg of RNA of each sample following the manufacturer's instructions (Hight Capacity cDNA Reverse Transcriptic Kit; Applied Biosystems). Fast Real-time qPCR was performed using the SYBR Green method (Fast SYBR Green Master Mix, Applied Biosystems) with the QuantStudio 3
Real-Time PCR System (Applied Biosystems). Relative mRNA expression was determined by the 2 −ΔΔCT method (Pfaffl, 2001) , and normalized to GAPDH levels.
IGF-I administration:
Human recombinant IGF-I (Pre-Protech, USA) or vehicle (saline) were administered intracerebroventricularly (icv, 50 µg/kg/day) using Alzet osmotic mini-pumps for 7 days (Model 1007D), and the brain infusion kit 3 (Alzet, USA) with the following stereotaxic coordinates: AP= -0.5; ML= 1.1; DV= -2.5. Alzet pumps were implanted subcutaneously between the scapulae.
Statistics:
Statistical analyses were performed with GraphPad Prism 6 software (San Diego, USA). Student's t-test (for comparing two groups) test for comparing two groups or either 1-way or 2-way ANOVAs (for more than 2 groups) followed by Tukey's multiple comparison test as a post hoc were performed. For non-normally distributed data, we used the Mann Whitney U. All results are shown as mean ± standard error (SEM) and significant values as: *p<0.05; **p<0.01; ***p<0.001. Figure 1A ,B for additional information; n=14-19 mice/group; Twoway-ANOVA followed by Tukey's multiple comparisons test). animals were retested to determine extinction recall by placing them in the same context. Firoc mice injected with mCherry show reduced extinction that was normalized after DREADD inhibition (n=7-8; One-way-ANOVA followed by Tukey's multiple comparisons test). B, Firoc mice submitted to fear conditioning show increased orexin expression in the hypothalamus (n= 5-6; Mann Whitney U Test). C, Firoc mice showed anhedonia as tested in the SPT that was rescued with DREADD-mediated chemogenetic inhibition of orexin neurons (n=6-8; One-way-ANOVA followed by Tukey's multiple comparisons test). Figure. A, B 
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